USPTO Ditches Unused COVID Patent Fast-Track Program
Published Date: 4/16/2026
Notice
Summary
The USPTO is ending its Fast-Track program that sped up COVID-19-related patent appeals because it wasn’t used much. Starting April 17, 2026, no new fast-track requests will be accepted, letting the office focus on speeding up all patent appeals instead. This change won’t cost anyone extra but means COVID-19 appeals will follow the regular review timeline from now on.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 1 costs, 1 mixed.
Use Broad Fast-Track Program Instead (Fee)
Applicants may instead request expedited handling under the USPTO's Fast-Track Appeals Pilot Program by filing a petition and paying a petition fee; that program sets a target of reaching a decision on the ex parte appeal within six months from the date the appeal is entered into the program. This gives a faster review but requires paying the petition fee.
No New COVID-19 Fast-Track Petitions
Starting after midnight ET on April 16, 2026, the USPTO will not grant any new petitions to participate in the Fast-Track for COVID-19-Related Appeals Pilot Program. COVID-19-related ex parte appeals filed after that time will follow the regular PTAB review timeline.
Existing Fast-Track Petitions Keep Status
If you filed a grantable petition for the COVID-19 fast-track by midnight ET on April 16, 2026, your ex parte appeal will keep its fast-track status. That fast-track status will remain until the PTAB's jurisdiction ends under 37 CFR 41.35(b), even if the appeal is still pending after the deadline.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-22924, Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Response to Office Action and Voluntary Amendment Forms
The USPTO is asking for public feedback on renewing forms used to respond to trademark office actions and make voluntary changes. This helps keep the process smooth and reduces paperwork hassle for businesses and inventors. Comments are open until December 10, 2026, so don’t miss your chance to weigh in!
2026-22798, Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; International Design Applications (Hague Agreement)
The USPTO is asking for public feedback on updating the paperwork for international design applications under the Hague Agreement. This affects designers and businesses wanting to protect their designs in multiple countries with one application. Comments are open until January 8, 2027, with no new fees announced, just smoother processing ahead!
2026-22193, Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; DOCX Submission Requirements
The United States Patent and Trademark Office (USPTO) is asking for public feedback on its DOCX submission rules, which affect anyone filing patent applications. They want to make sure the process is smooth and not too much work for applicants. Comments are open until November 30, 2026, so don’t miss your chance to weigh in!
2026-19613, Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Trademark Trial and Appeal Board (TTAB) Actions
The USPTO is asking for public feedback on its paperwork rules for the Trademark Trial and Appeal Board (TTAB). This helps make sure the forms are easy to use and don’t waste anyone’s time. If you’re involved in trademarks, now’s your chance to comment before October 26, 2026, with no new fees or big changes planned.
2026-19576, Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Generic Clearance for Information Pertaining to Events, Registrations, and Programs
The USPTO is asking for public feedback on a new plan to simplify how they collect info for events, registrations, and programs they run. This change will make it easier and faster to get approval for forms used at these events, affecting anyone who attends or participates. Comments are open until November 23, 2026, with no new costs expected.
2026-17524, Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Patent Trial and Appeal Board (PTAB) Appeals
The United States Patent and Trademark Office (hereafter "USPTO" or "Agency") will submit the following information collection request to the Office of Management and Budget (OMB) for review and clearance in accordance with the Paperwork Reduction Act of 1995, on or after the date of publication of this notice. The USPTO invites comments on the information collection renewal of 0651-0063, which helps the USPTO assess the impact of its information collection requirements and minimize the reporting burden to the public. Public comments were previously requested via the Federal Register on April 20, 2026, during a 60-day comment period (91 FR 20986). This notice allows for an additional 30 days for public comments.
Previous / Next Documents
Previous: 2026-07441, 60-Day Notice of Proposed Information Collection: Annual Report-J-NONIMMIGRANT Exchange Visitor Program
The U.S. Department of State wants to update the annual report form for J-1 Exchange Visitor Program sponsors. About 1,425 sponsors will spend around 2 hours each filling out the revised form. They’re asking for public comments by June 15, 2026, before finalizing the changes—so now’s the time to speak up if you’re involved!
Next: 2026-07443, Determination That CHEWTADZY (Tadalafil) Chewable Tablets, 5 Milligrams, 10 Milligrams, 20 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The FDA has decided that CHEWTADZY chewable tablets (5, 10, and 20 mg) were not taken off the market because of safety or effectiveness problems. This means generic versions can now get approved if they meet all the rules. Patients and drug makers can expect more affordable options soon, with no safety worries holding things back.